Star Imaging and Path Lab (544482) — Annual Report

📢 Key Event
FY26 revenue grew 6% YoY to ₹88.5 crore with EBITDA margin expanding to 37.5% and PAT margin reaching 21.8%.

🔄 What Changed
Revenue grew 6% YoY to ₹88.5 crore; EBITDA margin improved to 37.5% (from 34.3%); PAT margin rose to 21.8% (from 19.1%); net cash turned positive; ROCE improved to 29% (from 41.9%); operating cash flow improved to ₹23.3 crore (from -₹2.6 crore).

🔮 What's Next
Expanding diagnostic centre network across existing and new geographies; deepening specialised diagnostic capabilities in advanced imaging and molecular diagnostics; increasing pathology integration across radiology-led centres; strengthening B2C franchise and referral ecosystem; pursuing additional PPP opportunities across government healthcare infrastructure projects; continuing investments in technology, quality systems, and operational efficiency; launching new high-potential centres to strengthen market presence and operational scale.

💡 Investor Takeaway
The company is building a scalable, technology-driven diagnostics platform with strong cash flow generation and improving margins, positioning it for sustainable growth through network expansion and strategic PPP partnerships.

Star Imaging and Path Lab Limited reported FY26 revenue of ₹88.5 crore, up 6% YoY, with EBITDA margin expanding to 37.5% and PAT margin reaching 21.8%. The company turned net cash positive, improved ROCE to 29%, and strengthened its balance sheet. Management highlighted strategic focus on expanding diagnostic centres, deepening specialised capabilities in molecular diagnostics, and pursuing PPP opportunities in government healthcare. The Board reappointed Executive Director Neelam Ratra and emphasized continued investment in technology and scalable hub-and-spoke operations to drive sustainable growth.

📄 View Original Announcement (PDF)

📊 Stock Analysis — 544482 ✨ Ask AI About This

About Star Imaging and Path Lab Ltd (544482)

Healthcare · Healthcare · Listed on BSE

Market Cap: ₹145.07 Cr

View full 544482 stock details →

📡 Get AI alerts when 544482 files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track 544482 — Free

💡 Ask AI about this filing

"What is the projected revenue growth rate for FY27 based on management's outlook?" "How will the company's PPP expansion impact revenue contribution from government contracts?" "What specific technology investments are planned to enhance molecular diagnostics capabilities?"

Ask AI Free →

📊 More 544482 filings

See all 544482 filings →

🔥 Also filed on 1 September 2026

FORTIS Fortis Healthcare Ltd Announcement SUNPHARMA Sun Pharmaceutical Industries Ltd Announcement 544083 Shree Marutinandan Tubes Ltd Annual Report SUDARSCHEM Sudarshan Chemical Industries Ltd Announcement JNPR Juniper Green Energy Ltd Announcement SUDARSCHEM Sudarshan Chemical Industries Ltd Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts for your stocks — summarized by AI daily

Set up your AI Radar — pick stocks, get daily email summaries of new filings.

Set up AI Radar — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd

Star Imaging and Path Lab Ltd (544482) — FY26 Annual Report | 1 September 2026

About Star Imaging and Path Lab Ltd (544482)

📡 Get AI alerts when 544482 files next

💡 Ask AI about this filing

📊 More 544482 filings

🔥 Also filed on 1 September 2026